Although B16F10 cells express low level of TAPBPL, anti‐hTAPBPL mAb also significantly inhibited the growth of B16F10 melanoma cells, as compared to control antibody treatment (Fig 7M and Fig EV5J). The gene discussed is TAPBPL; the disease is melanoma.